HæmatoLOGIK
by dansk podcast
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 4 chart positions in 4 markets.
By chart position
- 🇸🇪SE · Life Sciences#9610K to 30K
- 🇩🇰DK · Life Sciences#1730K to 100K
- 🇫🇮FI · Life Sciences#913K to 10K
- 🇳🇴NO · Life Sciences#114500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
22K to 72K🎙 Weekly cadence·63 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
44K to 143K🇩🇰70%🇸🇪21%🇫🇮7%+1 more - Active Followers
Loyal subscribers who consistently listen
13K to 43K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 16 epsHosts
Recent guests
Recent episodes
[ AML ] Menin-hæmmere ved akut leukæmi /m. Ulrik Overgaard og Troels Hammer
Jul 7, 2026
42m 14s
[ Benign hæmatologi ] Splenomegali som tilfældighedsfund /m. gæst Jens Helby
Jun 30, 2026
43m 59s
[ Benign hæmatologi ] Tilfældighedsfund i hæmatologien /m. gæst Jens Helby
Jun 23, 2026
43m 42s
[ CLL ] Førstelinje behandling af CLL i 2026 /m. gæst Christian Poulsen
Jun 15, 2026
53m 16s
[ CLL ] Fixed-Duration versus Continuous Treatment for CLL /m. gæst Christian Poulsen
Jun 8, 2026
57m 34s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/7/26 | acute leukemiamenin inhibitors+3 | Ulrik Overgaard | RigshospitaletMenin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)+3 | — | menin-hæmmereakut leukæmi+3 | — | 42m 14s | ||
| 6/30/26 | splenomegalihæmatologi+3 | Jens Helby | RigshospitaletIncidentally Detected Splenomegaly and Risk of Hematologic Cancer and Liver Disease | — | splenomegalihæmatologi+3 | — | 43m 59s | ||
| 6/23/26 | hæmatologiblodprøve+3 | Jens Helby | RigshospitaletHæmatoLOGIK+2 | — | hæmatologitilfældighedsfund+3 | AbbVie | 43m 42s | ||
| 6/15/26 | CLL treatmentfirst-line therapy+3 | Christian Poulsen | CLL17-studietKFE+2 | — | CLLtreatment+5 | — | 53m 16s | ||
| 6/8/26 | Chronic Lymphocytic Leukemiatreatment comparison+4 | Christian Poulsen | Sjællands UniversitetshospitalKøbenhavns Universitet+1 | — | CLLtreatment+5 | — | 57m 34s | ||
| 5/28/26 | hematologyNordic Hema Night+3 | Ulrik OvergaardEmilie Clausen | RigshospitaletAbbvie | — | hematologyNordic Hema Night+5 | — | 1m 57s | ||
| 2/25/26 | benign hematologypyruvate kinase deficiency+3 | Andreas Glenthøj | hearHEARHæmatoLOGIK+4 | — | pyruvate kinasebenign hematology+3 | AbbVie | 51m 46s | ||
| 2/18/26 | hæmatologihæmolytiske anæmier+4 | Andreas Glenthøj | Dansk Center for Røde BlodcellerhearHEAR | — | hæmolytiske anæmierdiagnostik+5 | AbbVie | 50m 51s | ||
| 2/11/26 | fungal infectionshematology+3 | Marie Helleberg | hearHEARHæmatoLOGIK+1 | — | fungal infectionshematology+3 | AbbVie | 47m 54s | ||
| 2/4/26 | infektionssygdommehæmatologi+3 | Marie Helleberg | RigshospitaletHæmatoLOGIK | — | infektionhæmatologi+3 | AbbVie | 44m 39s | ||
| 12/21/25 | diagnosticshematology+3 | Troels Hammer | RigshospitalethearHEAR | — | trombocytopeniableeding disorders+3 | AbbVie | 20m 44s | ||
| 12/14/25 | diagnosticshyperinflammation+3 | Marie Helleberg | RigshospitaletHæmatoLOGIK+1 | — | hyperinflammationlung infiltrates+3 | AbbVie | 26m 53s | ||
| 12/7/25 | diagnosticshealthcare+4 | Gustav Mathiasen | RigshospitalethearHEAR | — | diagnosticselderly patient+3 | AbbVie | 24m 09s | ||
| 11/30/25 | diagnosticshematology+3 | — | RigshospitalethearHEAR | — | diagnosticshematology+3 | AbbVie | 31m 05s | ||
| 11/11/25 | genetic predispositiontelomere diseases+3 | Marie Bill | Aarhus UniversitetshospitalVejle Sygehus+3 | — | telomere diseasesDDX41+3 | AbbVie | 36m 22s | ||
| 11/4/25 | genetic predispositionmyeloid diseases+3 | Marie Bill | Aarhus UniversitetshospitalVejle Sygehus+1 | — | RUNX1TP53+4 | — | 43m 45s |
![[ AML ] Menin-hæmmere ved akut leukæmi /m. Ulrik Overgaard og Troels Hammer episode artwork](https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/5d078673b720c7cc16f76fa4eacc7a13.jpg){kind=small}
![[ Benign hæmatologi ] Splenomegali som tilfældighedsfund /m. gæst Jens Helby episode artwork](https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/10594ddc438ad8464b31fa83903891d6.jpg){kind=small}
![[ Benign hæmatologi ] Tilfældighedsfund i hæmatologien /m. gæst Jens Helby episode artwork](https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/9fc612865b1d685ff7e3b2af70b580fa.jpg){kind=small}
![[ CLL ] Førstelinje behandling af CLL i 2026 /m. gæst Christian Poulsen episode artwork](https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/c1c0f6b212b12a5b6cbc09a3528c0d44.jpg){kind=small}
![[ CLL ] Fixed-Duration versus Continuous Treatment for CLL /m. gæst Christian Poulsen episode artwork](https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/31ed9204d60fedc9b02e9fe1ce8ecf54.jpg){kind=small}
![[ Benign hæmatologi ] Pyruvatkinase mangel /m. gæst Andreas Glenthøj episode artwork](https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/7d4ef54bfa471256b2cc813e0c0387f7.jpg){kind=small}
![[ Benign hæmatologi ] Hæmolyse og diagnostik /m. gæst Andreas Glenthøj episode artwork](https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/c50306296ce5844763aefde34e83b8c4.jpg){kind=small}
![[ Infektion ] Svampeinfektioner i hæmatologien /m. gæst Marie Helleberg episode artwork](https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/41bb1b5e4f1e6390ad3105fef2b885b6.jpg){kind=small}
![[ Infektion ] Alt om infektionssygdomme i hæmatologien /m. gæst Marie Helleberg episode artwork](https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/6fe5ac0d64b028baed701625480348f8.jpg){kind=small}
![[ Genetisk prædisposition ] Cases: Telomer-sygdomme og DDX41 /m. gæst Marie Bill episode artwork](https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/aa78dd104ea8a7093200efdd5b50adc7.jpg){kind=small}
![[ Genetisk prædisposition ] Cases: RUNX1 & TP53 /m. gæst Marie Bill episode artwork](https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/ea485b50a03bc16956bb5c1b20fe1570.jpg){kind=small}
Showing 16 of 16
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for HæmatoLOGIK
Peaked at #17 in Denmark, currently #17 in Denmark.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| Denmark | — | #17 | #17 | — |
| Finland | — | #91 | #91 | — |
| Sweden | — | #96 | #96 | — |
| Norway | — | #114 | #114 | — |
| Denmark | — | #170 | #170 | — |
Chart Positions
5 placements across 4 markets.
Chart Positions
5 placements across 4 markets.